Medical Devices — D&A
Business Segments · D&AJohnson & Johnson Medical Devices — D&A increased by 5.2% to $886.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.3%, from $818.00M to $886.00M. Over 3 years (FY 2021 to FY 2024), Medical Devices — D&A shows an upward trend with a 14.8% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2017
Last reportedQ3 2025
Rolls up toD&A
How to read this metric
Higher values indicate a larger asset base or significant recent capital investments that are being expensed over time.
Detailed definition
This is the combined non-cash expense representing the allocation of the cost of tangible and intangible assets over the...
Peer comparison
Standard operating expense metric found in segment-level cash flow and income statements.
Metric ID:
jnj_segment_medtech_depreciation_and_amortizationHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $535.00M | $535.00M | $535.00M | $575.50M | $575.50M | $575.50M | $575.50M | $735.75M | $735.75M | $735.75M | $735.75M | $746.00M | $806.00M | $818.00M | $867.00M | $836.00M | $842.00M | $886.00M |
| QoQ Change | — | +0.0% | +0.0% | +7.6% | +0.0% | +0.0% | +0.0% | +27.8% | +0.0% | +0.0% | +0.0% | +1.4% | +8.0% | +1.5% | +6.0% | -3.6% | +0.7% | +5.2% |
| YoY Change | — | — | — | — | +7.6% | +7.6% | +7.6% | +27.8% | +27.8% | +27.8% | +27.8% | +1.4% | +9.5% | +11.2% | +17.8% | +12.1% | +4.5% | +8.3% |
Range$535.00M – $886.00M
CAGR+12.6%
Avg YoY Growth+14.2%
Median YoY Growth+10.4%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medical devices — d&a?
- Johnson & Johnson (JNJ) reported medical devices — d&a of $886.00M in Q3 2025.
- How has Johnson & Johnson's medical devices — d&a changed year-over-year?
- Johnson & Johnson's medical devices — d&a increased by 8.3% year-over-year, from $818.00M to $886.00M.
- What is the long-term trend for Johnson & Johnson's medical devices — d&a?
- Over 3 years (2021 to 2024), Johnson & Johnson's medical devices — d&a has grown at a 14.8% compound annual growth rate (CAGR), from $2.14B to $3.24B.
- What does medical devices — d&a mean?
- The total non-cash expense for the wear and tear of equipment and the expiration of intangible assets in the medical technology segment.